Bellicum Pharmaceuticals Company
Bellicum is engineering high-performance cellular immunotherapies and unleashing their power against a wide range of cancers, impacting more patients than ever.
Funding Status:
IPO
Founded Date:
01.07.2004
Technology:
Сancer Diagnostics
Estimated Revenue:
Less than $1M
Industry:
Genomic and Epigenominc Instabillity
Headquarters:
United States